Open AccessIn vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid
Author(s) -
Joan S. Knapp,
Arthur F. Back,
Anna Babst,
David N. Taylor,
Roselyn J. Rice
Publication year - 1993
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.37.7.1552
Subject(s) - haemophilus ducreyi , cefixime , chancroid , microgram , microbiology and biotechnology , ciprofloxacin , trimethoprim , antibacterial agent , penicillin , tetracycline , ceftriaxone , antibiotics , biology , pasteurellaceae , haemophilus influenzae , in vitro , virology , human immunodeficiency virus (hiv) , syphilis , biochemistry
We determined the in vitro susceptibilities of 54 isolates of Haemophilus ducreyi from Thailand (29 isolates) and San Francisco (25 isolates) to penicillin G, tetracycline, amoxicillin-clavulanic acid, ceftriaxone, cefixime, erythromycin, azithromycin, ciprofloxacin, ofloxacin, and trimethoprim-sulfamethoxazole. Isolates were susceptible to or = 8.0 micrograms of tetracycline per ml, 11.1% of the isolates were resistant to and 40.9% of the isolates were resistant to trimethoprim-sulfamethoxazole (MIC, > or = 4/76 microgram/ml.)